Albenza Related Published Studies
Well-designed clinical trials related to Albenza (Albendazole)
Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: Effect on long-term seizure outcome. [2008.10.11]
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. [2008.09]
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. [2008.08.20]
The effects of albendazole treatment on neurocysticercosis: a randomized controlled trial. [2008.05.21]
Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. [2008.05.01]
Tribendimidine and Albendazole for Treating Soil-Transmitted Helminths, Strongyloides stercoralis and Taenia spp.: Open-Label Randomized Trial. [2008]
Albendazole for the treatment of human echinococcosis: a review of comparative clinical trials. [2007.09]
Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. [2007.07]
Efficacy of preoperative albendazole use according to months in hydatid cyst of the liver. [2007.03]
Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province. [2007.03]
Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. [2007.01]
Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes. [2006.10]
Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran. [2006.09]
Effect on weight gain of routinely giving albendazole to preschool children during child health days in Uganda: cluster randomised controlled trial. [2006.07.15]
Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. [2006.05.13]
A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. [2006.04.15]
Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations. [2006.04]
Albendazole: single or combination therapy with permethrin against pediculosis capitis. [2006.03]
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. [2006.02.14]
Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis. [2006]
Albendazole for lymphatic filariasis. [2005.10.19]
Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children. [2005.07]
Periodic deworming with albendazole and its impact on growth status and diarrhoeal incidence among children in an urban slum of India. [2005.04]
Liver hydatid disease: morphological changes of protoscoleces after albendazole therapy. [2005.03]
Efficacy of albendazole against the whipworm trichuris trichiura--a randomised, controlled trial. [2004.12]
Albendazole therapy for Microsporidium diarrhea in immunocompetent Costa Rican children. [2004.10]
Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis. [2004.10]
The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. [2004.09]
Human loiasis in a Cameroonian village: a double-blind, placebo-controlled, crossover clinical trial of a three-day albendazole regimen. [2004.08]
The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. [2004.08]
[Nitazoxanide vs albendazole against intestinal parasites in a single dose and for three days] [2004.07]
Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis. [2004.06]
Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey. [2004.06]
Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. [2004.05]
Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study. [2004.04.15]
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. [2004.04]
Comparative efficacy of albendazole and three brands of mebendazole in the treatment of ascariasis and trichuriasis. [2004.03]
Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. [2004.03]
A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. [2004.02]
The effectiveness of 3, 5 or 7 days of albendazole for the treatment of Trichuris trichiura infection. [2003.12]
Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. [2003.07]
Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. [2003.07]
Time dependent pharmacokinetics of albendazole in human. [2003.07]
Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis. [2003.06]
Placental and fetal toxicity of albendazole sulphoxide in Wistar rats. [2003.06]
The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus. [2003.03]
One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial. [2003.03]
A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. [2003]
Dose dependent pharmacokinetics of albendazole in human. [2002.12]
Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia. [2002.10]
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. [2002.09]
Morphometry of single small enhancing computed tomographic lesions: outcome and effect of albendazole therapy. [2002.08]
Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. [2002.03]
Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: follow-up after re-treatment with the combination. [2002.03]
[Ascariasis: comparison of the therapeutic efficacy between paico and albendazole in children from Huaraz] [2001.07]
A comparative trial of albendazole alone versus combination of albendazole and praziquantel for treatment of Trichuris trichiura infection. [2001.06]
Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. [2001.05]
A comparative study of different albendazole and mebendazole regimens for the treatment of intestinal infections in school children of Usigu Division, western Kenya. [2001.04]
Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone). [2001.03]
Albendazole versus placebo in treatment of echinococcosis. [2001.03]
Effects of tail amputation and treatment with an albendazole controlled-release capsule on the health and productivity of prime lambs. [2000.12]
Effect of dose increase or cimetidine co-administration on albendazole bioavailability. [2000.11]
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations. [2000.09]
Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. [2000.07]
Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. [2000.04]
A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana. [2000.03]
Effectiveness and cost-effectiveness of albendazole in improving nutritional status of pre-school children in urban slums. [2000.01]
A study on the provocative day test effect of ivermectin and albendazole on nocturnal periodic Wuchereria bancrofti microfilaraemia. [1999.11]
Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations. [1999.09]
A placebo controlled study of albendazole in the treatment of pulmonary echinococcosis. [1999.09]
Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka. [1999.07]
Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. [1999.04]
Single-day praziquantel versus 1-week albendazole for neurocysticercosis. [1999.03.23]
Albendazole treatment for Giardia intestinalis infections in school children. [1999.03]
Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren. [1999.03]
Comparison of the efficacy of mebendazole, albendazole and pyrantel in treatment of human hookworm infections in the southern region of Mali, West Africa. [1999.03]
Lipidic matrix of albendazole sulphoxide: is it an alternative for systemic infections? [1998.11]
The pharmacokinetics and efficacy of long-term low-level and split-dose administration of albendazole through in-feed formulations against ovine and caprine parasitic gastroenteritis. [1998.11]
Randomised trial of albendazole and pyrantel in symptomless trichuriasis in children. [1998.10.03]
Lipidic matrix of albendazole: an alternative for systemic infections. [1998.10]
Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. [1998.08]
A comparison of mebendazole and albendazole in treating children with Trichuris trichiura infection in Durban, South Africa. [1998.07]
Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial. [1998.05]
Comparative efficacy of pyrethrum marc with albendazole against sheep gastrointestinal nematodes. [1998.02]
Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. [1998.01]
[Field trials on the efficacy of albendazole composite against intestinal nematodiasis] [1998]
Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. [1997.08.16]
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. [1997.05]
The effects of a controlled-release albendazole capsule (Proftril-Captec) on parasitism in grazing Corriedale ewes in the Nyandarua district of Kenya. [1997.02]
Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone. [1997.02]
Comparative trials using albendazole and mebendazole in the treatment of soil-transmitted helminths in schoolchildren on Penang, Malaysia. [1996.12]
A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. [1996.11]
Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial. [1996.05.11]
Vitamin A status of Indonesian children infected with Ascaris lumbricoides after dosing with vitamin A supplements and albendazole. [1996.02]
A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. [1995.12]
The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole. [1995.12]
[Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis] [1995.12]
Albendazole in neurocysticercosis. [1995.11]
Treatment of porcine cysticercosis with albendazole. [1995.11]
[Randomized study comparing the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children] [1995.10]
Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man. [1995.10]
|
